Endocannabinoids, CB1 receptors, and liver disease: hitting more than one bird with the same stone.
Kunos
George
G
Gao
Bin
B
D063385:Cannabinoid Receptor Modulators / Q000502:physiology*; D063388:Endocannabinoids; D005234:Fatty Liver / Q000503:physiopathology*; D019698:Hepatitis C, Chronic / Q000503:physiopathology*; D006801:Humans; D008099:Liver / Q000378:metabolism / Q000473:pathology; D008385:Marijuana Smoking / Q000009:adverse effects; D043884:Receptor, Cannabinoid, CB1 / Q000378:metabolism; D043885:Receptor, Cannabinoid, CB2 / Q000378:metabolism; D012307:Risk Factors; D012720:Severity of Illness Index
D063385:Cannabinoid Receptor Modulators; D063388:Endocannabinoids; D043884:Receptor, Cannabinoid, CB1; D043885:Receptor, Cannabinoid, CB2